Conference item icon

Conference item

Preclinical studies of WVE-210201, an investigational stereopure antisense oligonucleotide in development for the treatment of patients with duchenne muscular dystrophy (DMD)

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.jns.2017.08.791

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Physiology Anatomy & Genetics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Department of Paediatrics
Sub department:
Department of Physiology Anatomy and Genetics
Role:
Author


Publisher:
Elsevier
Host title:
Journal of the Neurological Sciences
Journal:
Journal of the Neurological Sciences More from this journal
Volume:
381
Issue:
Supplement
Pages:
277-278
Publication date:
2017-10-15
DOI:
EISSN:
1878-5883
ISSN:
0022-510X


Keywords:
Pubs id:
pubs:834994
UUID:
uuid:0e057852-a3c1-46f5-90c0-98df41779353
Local pid:
pubs:834994
Source identifiers:
834994
Deposit date:
2019-06-26
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP